NCRRs Division of Comparative Medicine (DCM) participates, along with other
NIH components, in two Federal grant programs that provide funding to small businesses.
The Small Business Innovation Research (SBIR) Program and the Small Business Technology
Transfer (STTR) Program both seek to increase the participation of small businesses
in Federally supported research and development (R&D) and to increase private
sector commercialization of technology developed through Federally supported R&D.
However, there are significant differences between the two programs. For detailed
program information, refer to the NIH Small Business Opportunities Web site.
Typically, the DCM requests applications for grants, but it may also solicit contract
proposals. The DCM is especially interested in funding research to develop biomedical
methods and technologies that relate to improvements in laboratory animal care,
use, and management. Interest areas include, but are not limited to: controlling
laboratory animal diseases; improving culture, preservation, or management of
laboratory animals; and methods for identifying or producing new animal models.
For additional information in areas of interest to DCM, see contact information
below.
-
(R43-R44) Small Business Innovation Research (SBIR) grants support domestic
small business concerns to engage in research/research and development that has
the potential for commercialization. Phase I, which uses the R43 funding mechanism,
is normally for six months or longer for an amount up to $100,000. Phase II, which
uses the R44 funding mechanism, is for two years and for up to $750,000. Receipt
deadlines for applications are April 1, August 1, and December 1 of each year.
Refer to the Comparative Medicine Program Guidelines - January 1999 for appropriate
examples of technological areas of interest to DCM.
-
(R41-R42) Small Business Technology Transfer (STTR) grants support innovative
research in the United States that results in commercial products or services
that benefit the public. An STTR grant requires research partners at universities
and other non-profit research institutions to have a formal collaborative relationship
with the small business concern. At least 40 percent of the STTR research project
is to be conducted by the small business concern and at least 30 percent of the
work is to be conducted by the single, "partnering" research institution.
Phase I, which uses the R41 funding mechanism, is for one year for an amount up
to $100,000. Normally, Phase II, which uses the R42 mechanism, is for two years
and for up to $500,000. This total includes direct costs, indirect costs, and
fixed fees. If justified, applicants may propose longer periods of time and greater
amounts of funds. Receipt deadlines for applications are April 1, August 1, and
December 1 of each year. Refer to the Comparative Medicine Program
Guidelines - January 1999 for appropriate examples of technological areas of interest to
DCM.
|